28 rue Laennec Centre Léon Bérard, Lyon, Rhône, 69008, France
Develops therapeutic molecules targeting cancer dependence receptors.
Total Raised
$17 M
Rounds
2
Links
Verticals
Grant
May 2026
$8M
Series A
Dec 2023
Patrick Mehlen
Founder and Chief Executive Officer
Sebastien Hazard
Chief Medical Officer
Christophe Guichard
Chief Businesss Officer, CFO and Board Member
Fabien Sebille
Chief Business Officer
